Current Status of Bruton’s Tyrosine Kinase Inhibitor Development and Use in B-Cell Malignancies

Drugs & Aging ◽  
2017 ◽  
Vol 34 (7) ◽  
pp. 509-527 ◽  
Author(s):  
Andrew Aw ◽  
Jennifer R. Brown
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Current Status ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase ◽  
Inhibitor Development

Phase I, first-in-human trial of Bruton’s tyrosine kinase inhibitor M7583 in patients with B-cell malignancies

2021 ◽  
pp. 1-8
Author(s):  
Wojciech Jurczak ◽  
Simon Rule ◽  
William Townsend ◽  
David Tucker ◽  
Barbara Sarholz ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Phase I ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase ◽  
Human Trial

scholarly journals Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies

2015 ◽  
Vol 1358 (1) ◽  
pp. 82-94 ◽  
Author(s):  
Urte Gayko ◽  
Mann Fung ◽  
Fong Clow ◽  
Steven Sun ◽  
Elizabeth Faust ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase

scholarly journals Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies

2018 ◽  
Vol 29 ◽  
pp. viii362-viii363 ◽  
Author(s):  
W. Jurczak ◽  
S. Rule ◽  
W. Townsend ◽  
D. Tucker ◽  
B. Sarholz ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Phase I ◽  
B Cell ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
B Cell Malignancies ◽  
Bruton's Tyrosine Kinase ◽  
Human Trial
Sign in / Sign up

Export Citation Format

Share Document